Study successfully achieved both primary endpoints Second positive Phase 3 demonstrating the safety and efficacy of IMVAMUNE and final study required for licen...

ITU leads United Nations dialogue on Artificial Intelligence The 2nd AI for Good Global Summit at ITU Headquarters in Geneva, 15-17 May 2018, will take action to ensu...

Fexinidazole would be first all-oral treatment* under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa S...